Achieve life sciences announces agreement with the freemind group

Achieve life sciences announces agreement with the freemind group to assist in securing non-dilutive funding to evaluate cytisinicline in vaping and e-cigarette users.achieve life sciences inc - co and freemind will conduct a strategic assessment of potential non-dilutive funding opportunities.

ACHV Ratings Summary

ACHV Quant Ranking